Documente Academic
Documente Profesional
Documente Cultură
HORMONE
the chemical messengers produced by the endocrine cells that travel through the circulation to specific body cells
body cells contain receptors for specific hormones called TARGET CELLS
only those cells containing receptors will bind hormones very specific, concn dependent & reversible
CLASSIFICATION OF HORMONES
A. PROTEIN HORMONES
synthesized in the endocrine glands as a larger precursor molecules called PREPROHORMONES contains a leader sequence of
AA called SIGNAL SEQUENCE cleaved from the molecules called PROHORMONES enzymatically cleaved to smaller molecules
active hormones packaged into secretory vesicles
does not attach to plasma CHONS & circulates in the blood as free hormone
STEROID HORMONES
synthesized in the cytoplasm by multienzyme processes
derived from CHOLESTEROL
separated into groups based on the no. of carbon presents:
C 18 estrogens
C 19 androgens
C 21 gluococorticoids, mineralocorticoids & progesterone
freely diffuse across the plasma mem. & into the bloodstream
bind to specific plasma CHON w/c allows them to remain in circulation for longer than the unbound or free form of the
hormone
take longer to initiate their action & once started, the action is sustained for a prolonged period
longer half life bec. of their binding to the plasma CHON carriers
composed of AA & share many of the same charac. as the CHON hormones
from indiv. cells or group of cells
has its own specific extracellular receptor since they cannot cross the plasma mem.
NEUROTRANSMITTERS (NT)
epinephrine/norepinephrine may serve as either a hormone or NT, the diff. is the site of synthesis & action
the final hormone produced regulates its own secretion by inhibiting the secretion of 1 or more of the precursor hormones
TRH (Thyroid Releasing H) by hypothalamus
TH by thyroid gland
B.
POSTIVE FEEDBACK
the final hormone produced actually enhances or induces the initial hormone & causes its own prodxn to be
rare; final hormone enhances or induces initial hormone production
Oxytocin
MECHANISM OF ACTION
A. PROTEIN HORMONE ACTION
activates an intracellular CHON (G) to transducer the signal to an enzyme (adenyl cyclase) to produce 2 nd messenger cAMP
B.
Bind to EC receptors Hormone-receptor complex Activate IC protein (G) transduce signal to Adenyl cyclase
(enzyme) produce 2nd messenger cAMP cause IC changes
a heat shock CHON dissociates from the receptor after binding
hormone-receptor complex migrates into the nucleus & binds w/ a specific region on the DNA
1.
2 categories:
1 DISORDERS
problem w/ the gland that produces the hormone (hyper/hyposecretion), the outside stimulating agents is N
Hyper more difficult to correct than hypo
Hypo not detected until 80-90% of gland is nonfunctional
2.
2 DISORDERS
the gland that produces the hormone is capable of N fxn, the outside stimulating agents are either in excess or deficient
hypersecretion of a hormone is often more difficult to correct than hyposecretion
hyposecretion is often not detected until approx. 80%-90% of the gland is nonfunctional
normal gland function, outside stimulating agents in excess or deficient
HYPOTHALAMUS
-
part of brain; under 3rd ventricle & directly above pituitary gland
secrete neuropeptides (hormones): inhibit/ stimulate hormones of Anterior Pituitary Gland (APG); regulatory hormones
neurosecretory cells secrete the neuropeptides
Hypothalamic Hormones:
Corticotropin
Releasing Hormone (CRH)
Thyrotropin
Releasing Hormone (TRH)
TSH
FSH, LH
prolactin (PRL)
PRL
GH
GH
Melanocyte-Stimulating H
Oxytocin
Pineal gland
on the posterior wall of the 3rd ventricle of the cerebrum
small pine-cone shaped structure
exact fxn unknown; but synthesizes MELATONIN (synthesized from serotonin; can inhibit gonadotropic hormone in lower
vertebrates {may or may not in humans})
3rd eye: regulates the circadian rhythm/ diurnal pattern
production in dim light - sleepy, tired, depressed during nighttime
Bright light inhibits melatonin active, awake during daytime
connected to the hypothalamus by infundibulum or pituitary stalk through w/c the neuropeptides migrate to pit. gland
contained in a depression of sphenoid bone: SELLA TURCICA; adjacent to chiasm of optic nerve
Master Gland - secretes numerous hormones w/c triggers other glands to produce hormones
enlargement leads to loss of vision
2 main lobes:
a. Posterior Pituitary/ Neurohypophysis smaller hypothalamic lobe; storage of Oxytocin (targets the breast and the uterus) &
ADH/AVP (target organ is the kidney); synthesized in Hypothalamus; neuroectodermal in origin
b. Anterior Pituitary/ Adenohypophysis specialized secretory epith. cells: synthesize & stimulate numerous hormones
stimulates the secretion of other hormones except GH & PRL
regulate their own secretion by a (-) Feedback to Hypothalamus short loop (-) feedback
TSH, ACTH, LH,FSH, except PRL & GH - others can stimulate other adrenal glands to produce H.
TSH (thyroid stimulating hormone) T3(triiodothyronin) and T4 (thyroxin)
ACTH (adenocorticotrophic hormone)- target organ is the adrenal cortex; end hormone produced is cortisol
LH and FSH target organs are the gonads (testes for males; ovaries for females); testosterone is produced in males, estrogen
and progesterone for females
Growth factor- stimulates tissues such as cartilage, bones, muscles but these do not produce hormones
Prolactin target organ is the breast; increase the size of the breast to prepare it to produce milk
Secretory Cells of AP (staining property with H&E)
1. Acidophils - stains red; Somatotrophs (secrete GH) & lactotrophs/ mammotrophs (secrete PRL)
2. Basophils stains blue; thyrotrophs (secrete TSH) and Gonadotrophs (secrete FSH and LH)
3. Chromophobe Cells dont stain; corticotrophs (secrete ACTH)
Pituitary hormones (based on chemical configuration):
1. Polypeptides hormones with intramolecular disulfide bonds (GH & PRL)
2. Glycoproteins TSH, FSH, LH; share common -subunit, differ in -subunit; ex: human chorionic gonadotrophin (hCG)
3. Single-chain peptides hormones w/o disulfide bonds (ACTH)
POSTERIOR PITUITARY HORMONES
- ADH & Oxytocin nonapeptides: contain 9 amino acids
- both are inhibited by alcohol
ADH (binds) to
V2 receptor (vasopressin) in distal convoluted tubules & collecting ducts activates
Adenyl Cyclase that will cause generation of
cAMP (cyclic adenosine monophosphate); (serves as the 2nd messenger: responsible for intracellular changes) initiates
phosphorylation of membrane CHON which causes
in membrane permeability to H2O
Polydipsia ( thirst)
2)
Laboratory Analysis
A.
-
ADH (pg/mL)
270-280
280-285
285-290
290-295
295-300
<1.5
<2.5
1-5
2-7
4-12
B.
B.
B.
B.
2. Oxytocin (OT)
most active in pregnant women
At term stimulates contraction of smooth muscles in the wall of the uterus (induce labor)
Synthetic oxytocin can be used to induce labor
induces lactation by stimulating contraction of the myoepethielial cells in the mammary glands (ejection of milk)
premature labor prevented by injecting alcohol intravenously
Nonpregnant women and men have basal levels of OT its role not been determined
2 Strongest Stimuli for Oxytocin release:
a. Distention of the uterus
b. Neonatal suckling of the nipple
Lab Analysis
A.
-
Lab Analysis:
RIA method of choice
fresh serum/ heparinized plasma (EDTA: value)
RR (female) = 0-18 ng/ml
(male) = 0-4 ng/ml
A.
-
o
a.
b.
Clinical Applications:
1. DIABETES INSIPIDUS (Most common)
a) deficiency of ADH or
b) failure of the kidney to respond to ADH
-produce large amts of urine (polyuria) w/ low specific gravity and urine osmolality
a. function of ADH: reabsorption of H2O [DI: H2O not reabsorbed rather urine is excreted out]
symptoms: fatigue, severe dehydration, hypothermia and shock
2 types of DI
Neurogenic DI
- cause of the ADH deficiency may be a pituitary tumor, traumatic, or surgical injury, genetic, autoimmune or idiopathic
Nephrogenic DI
- normal to elevated plasma concentrations of ADH, kidney is unable to respond to the hormone.
- chronic renal dss such as chronic pyelonephritis, protein starvation, hypokalemia, sickle cell anemia, congenital defects in the
receptors in the kidney.
- other cause of excess ADH: propagene carcinoma
Diagnostic tests: plasma and urine osmolality
a. urine osmolality: low <400mOsm/kg
b. urine volume for 24hrs is (>3L)
c. normal plasma osmolality if the H2O intake has not been restricted
2.
-
3.
-
to
a.
b.
c.
prove GH deficiency:
exogenous insulin injection dangerous: induce severe hypoglycemia plasma GH coma
injection of CRH (Corticotropic Releasing Hormone)stimulate pituitary gland to secrete GH
strenuous exercise (20mins)
4. GH HYPERSECRETION
If overproduction of GH begins in childhood before the epiphyseal plates of the bones are closed: Gigantism
Assay for TT4 employ non-isotopic IA such as Fluorescense polarization immunoassay (FPIA) and chemilumiescence
Free Thyroxin (free T4)
o
Only 0.02%
o
Much better indicator of thyroid status than total &4
o
FT4: can enter cells and undergo conversion to the metabolically potent T3
o
Elevated in approximately 95% of hyperthyroid patients
TRIIODOTHYROININE (T3)
Total T3 useful in evaluating suspected thyrotoxicosis in which the FT4 is normal
Useful in diagnosing mild hyperthyroidism because T3 rises earlier and more markedly than does T4 in all common forms of
hyperthyroidism
Methods for measuring TT3: enzyme immunoassays (MEIA) and chemiluminescence
THRYOGLOBULIN
Storage form of the TH precursors
Measured primarily in the monitoring of patients with follicular or papillary thyroid cancer
Increased with stimulation by TSH, thyroid-simulating immunoglobulins (TSIg), TRH or hCG
The last parameter to normalize after thyrotoxicosis therefore useful in resolving thyroid history in the presence of normal
T4 and T4 but with symptoms of thyrotoxicosis
Measures by chemiluminescence
THYROID ANTIBODIES
Thyroid microsomal antibodies (TMAb)
o
Present in about 85% of px with Hashimotos thyroiditis
o
In 85% of those with Graves dieases
Anti-thyroglobulin antibodies (TgAb)
o
Found in 60% of patients with Hashimotos thyroditis
o
In 30% of patients with Graves diseases
o
*TMAba and TgAb: predictor of outcome of antithyroid drug therapy in patients with Graves disease
TSH receptor antibodies (TRAb) or Thyroid-Stimulating antibodies (TSIg)
o
*TMAb and TgAb: hemagglutination tests in which erythrocytes that have been coated with either Tg or
microsomes agglutinate when the respective antibody is present
o
*thyroid peroxidase (TPO) antibodies: main autoantigenic component of microsomes
TSH STIMULATION TEST:
Can detect abnormalities before TH concentrations are outside their reference ranges
Useful in distinguishing between pituitary and hypothalamic hypothyroidism, confirming mild hyperthyroidism in patients
whose free T3 and T4 are equivocal and yet whose other clinical findings are suggestive of thyrotoxicosis
Injecting 200-500ug of synthetic TRH after determining a baseline TSH level
15, 30 and 60 minutes TSH determinations
Side effects: headache, nausea, chest tightness and mild hypotension
CLINICAL APPLICATIONS:
HYPERTHYROIDISM
Increase in circulating TH both free and total
Asymptomatic
Associated with elevated free and total T4 and T3, accompanied by a markedly decreased sTSH
o
Thyrotoxicosis
Condition that occurs when excessive amounts of TH in circulation affect peripheral tissue
Manifestations:
Decreased weight with normal appetite
Nervousness
Sweating
Palpitations
Heat intolerance
Muscle weakness
Clinical signs: enlarged thyroid (goiter), eyelid retraction and tremor
THYROID STORM:
State of thyroid crisis that requires emergency treatment
May occur following an infection, childbirth, diabetic ketoacidosis, withdrawal of antithyroid drugs or therapeutic use of
radioiodine or surgical treatment in the thyrotoxic patients
Due to sudden increase in circulating TH
Symptoms: tachycardia, heart failure, high fever, nausea, vomiting and psychiatric disorders and coma
Hyperthyroidism divided into 3 categories:
o
Excess thyroid stimulators